Silgan raises 2026 adjusted EPS outlook; Q1 sales up 6%, net income falls
Silgan reported first-quarter 2026 net sales of $1.56 billion, up 6% from a year earlier, mainly from passing through higher raw material costs. Net income fell to $63.0 million, or $0.60 per diluted share, from $68.0 million, or $0.63, a year earlier, and the company raised its full-year 2026 adjusted EPS estimate to $3.73 to $3.93 from $3.70 to $3.90.
Key points
- Q1 2026 net sales $1.56 billion, up $94.6 million (6%); EBIT $126.6 million, down $3.9 million from $130.5 million
- Q1 2026 adjusted EPS $0.78 versus $0.82 a year earlier; GAAP diluted EPS $0.60 versus $0.63
- Full-year 2026 adjusted EPS estimate raised to $3.73 to $3.93 from $3.70 to $3.90; free cash flow estimate of approximately $450 million confirmed
- Q2 2026 adjusted EPS estimate of $0.92 to $1.02 versus $1.01 in Q2 2025
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:00 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 29, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.